Panacea Biotec Ltd
NSE :PANACEABIO BSE :531349 Sector : PharmaceuticalsBuy, Sell or Hold PANACEABIO? Ask The Analyst
BSE
prev close
OPEN PRICE
bid price (qty)
offer price (qty)
volume
Today's low / high
52 WK low / high
NSE
prev close
open price
bid price (qty)
offer price (qty)
volume
Today's' low / high
52 WK low / high
18 Nov 375.55 (4.99%) | 14 Nov 357.70 (4.99%) | 13 Nov 340.70 (1.55%) | 12 Nov 335.50 (-4.09%) | 11 Nov 349.80 (-2.15%) | 08 Nov 357.50 (-4.30%) | 07 Nov 373.55 (-5.00%) | 06 Nov 393.20 (4.27%) | 05 Nov 377.10 (5.00%) | 04 Nov 359.15 (3.23%) | 01 Nov 347.90 (4.96%) | 31 Oct 331.45 (4.99%) | 30 Oct 315.70 (3.97%) | 29 Oct 303.65 (2.26%) | 28 Oct 296.95 (4.98%) | 25 Oct 282.85 (-3.17%) | 24 Oct 292.10 (-4.93%) | 23 Oct 307.25 (-0.89%) | 22 Oct 310.00 (-5.00%) | 21 Oct 326.30 (-4.99%) | 18 Oct 343.45 (-2.36%) |
Price Chart Historical Data Technical Chart
Technical Analysis
Short Term Investors
Very Bullish
Medium Term Investors
Very Bullish
Long Term Investors
Very Bullish
Moving Averages
5 DMA
Bullish
353.51
10 DMA
Bullish
362.6
20 DMA
Bullish
336.76
50 DMA
Bullish
319.41
100 DMA
Bullish
241.15
200 DMA
Bullish
191.45
Intraday Support and Resistance
(Based on Pivot Points) |
Updated On Nov 18, 2024 04:00 PM For Next Trading Session
Pivots | Classic | Fibonacci | Camarilla | Woodie | DM |
---|---|---|---|---|---|
R3 | 393.61 | 384.58 | 379.28 | - | - |
R2 | 384.58 | 379.4 | 378.03 | 385.71 | - |
R1 | 380.06 | 376.21 | 376.79 | 382.32 | 382.33 |
P | 371.03 | 371.03 | 371.03 | 372.16 | 372.16 |
S1 | 366.51 | 365.85 | 374.31 | 368.77 | 368.78 |
S2 | 357.48 | 362.66 | 373.07 | 358.61 | - |
S3 | 352.96 | 357.48 | 371.82 | - | - |
Key Metrics
EPS
0
P/E
0
P/B
7.29
Dividend Yield
0%
Market Cap
2,300 Cr.
Face Value
1
Book Value
51.69
ROE
-4.07%
EBITDA Growth
13.42 Cr.
Debt/Equity
0.02
Shareholding History
Quarterly Result (Figures in Rs. Crores)
Panacea Biotec Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 149.02 | 158.96 | 150.01 | 122.26 | 154.77 |
PROFIT | -10.88 | -4.36 | -4.66 | -18.62 | 1.97 |
EPS | -1.35 | -0.37 | -0.23 | -2.59 | 0.77 |
Panacea Biotec Ltd Quaterly Results
Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | |
INCOME | 96.72 | 98.28 | 96.76 | 60.68 | 80.05 |
PROFIT | 3.2 | 0.43 | -1.37 | -13.78 | 1.29 |
EPS | 0.52 | 0.07 | -0.22 | -2.25 | 0.21 |
Profit & Loss (Figures in Rs. Crores)
Panacea Biotec Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 700.81 | 700.9 | 607.49 | 611.51 | 758.16 | 607.3 | 629.25 | 2397.38 | 579.9 | 603.14 | |
PROFIT | -105.96 | -66.53 | -62.36 | -73.98 | -288.05 | -159.82 | -147.66 | -197 | -94.64 | -33.96 | |
EPS | 0 | 0 | 0 | 0 | 5.64 | -29.1 | -24.11 | 176.05 | -5.51 | -0.25 |
Panacea Biotec Ltd Profit & Loss
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | ||
INCOME | 680.86 | 700.6 | 601.1 | 271.48 | 400.59 | 217.15 | 350.07 | 309.02 | 260.36 | 366.72 | |
PROFIT | -65.1 | -48.78 | -34.74 | -71.88 | -276.22 | -121.7 | -17.7 | -93.59 | -92.84 | 3.5 | |
EPS | 0 | 0.13 | 0 | 0 | 3.98 | -22.93 | -2.36 | -15.28 | -14.29 | 0.58 |
Balance Sheet (Figures in Rs. Crores)
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 12.12 | 11.11 | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 | 6.13 | 22.43 | 22.43 |
Reserves Total | 814.27 | 815.82 | 848.86 | -256.47 | 138.87 | 334.63 | 292.91 | 339.91 | 426.18 | 448.76 |
Equity Share Warrants | 0 | 0 | 0 | 0 | 32 | 0 | 0 | 0 | 0 | 0 |
Equity Application Money | 21.65 | 21.65 | 21.65 | 21.65 | 21.79 | 9.64 | 9.64 | 9.64 | 0 | 0.1 |
Total Shareholders Funds | 848.04 | 848.58 | 876.64 | -228.69 | 198.79 | 350.4 | 308.68 | 355.68 | 448.61 | 471.29 |
Minority Interest | -3.82 | -3.49 | -2.98 | -3 | -3.04 | -3.01 | -2.95 | 10.54 | 1.08 | 3.42 |
Secured Loans | 0 | 0.24 | 0.29 | 759.5 | 708.64 | 604.57 | 906.96 | 959.87 | 1,058.16 | 1,059.43 |
Unsecured Loans | 15 | 15 | 33.87 | 60.03 | 33.55 | 41.93 | 33.79 | 33.71 | 30.27 | 35.45 |
Total Debt | 15 | 15.24 | 34.16 | 819.53 | 742.19 | 646.5 | 940.75 | 993.58 | 1,088.43 | 1,094.88 |
Other Liabilities | 50.08 | 60.79 | 74.74 | 225.05 | 129.48 | 43.75 | 30.83 | 120.64 | 62.34 | 26.28 |
Total Liabilities | 909.3 | 921.12 | 982.56 | 812.89 | 1,067.42 | 1,037.64 | 1,277.31 | 1,480.44 | 1,600.46 | 1,595.87 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 1,326.51 | 1,330.83 | 1,317.48 | 1,261.62 | 1,274.64 | 1,392.9 | 1,605.84 | 1,600.07 | 1,620.29 | 1,633.48 |
Less: Accumulated Depreciation | 744.66 | 730.88 | 695.41 | 652.92 | 617.25 | 587.34 | 656.87 | 598.7 | 549.18 | 489.18 |
Net Block | 581.85 | 599.95 | 622.07 | 608.7 | 657.39 | 805.56 | 948.97 | 1,001.37 | 1,071.11 | 1,144.3 |
Capital Work in Progress | 101.5 | 42.32 | 17.26 | 34.42 | 24.01 | 22.51 | 39.93 | 30.41 | 160.95 | 155.48 |
Investments | 40.43 | 13.49 | 5.07 | 0.07 | 5.58 | 5.33 | 7.28 | 7.28 | 8.71 | 15.18 |
Inventories | 177.94 | 202.09 | 212.72 | 174.14 | 147.69 | 81.43 | 334.21 | 315.55 | 305.24 | 310.22 |
Sundry Debtors | 57.42 | 60.09 | 81.66 | 84.68 | 68.52 | 88.73 | 136.01 | 142.17 | 141.67 | 98.57 |
Cash and Bank Balance | 139.48 | 225.99 | 583.28 | 135.79 | 89.75 | 23.48 | 23.24 | 14.13 | 22.93 | 52.4 |
Loans and Advances | 69.98 | 60.73 | 67.9 | 116.36 | 377.31 | 314.25 | 64.87 | 61.31 | 76.02 | 59.55 |
Total Current Assets | 444.82 | 548.9 | 945.56 | 510.97 | 683.27 | 507.89 | 558.32 | 533.17 | 545.86 | 520.74 |
Current Liabilities | 273.01 | 292.97 | 740.28 | 351.27 | 315.48 | 323.97 | 314.04 | 299.8 | 251.94 | 327.91 |
Provisions | 35.82 | 36.7 | 36.03 | 13.37 | 7.41 | 13.92 | 6.95 | 8.81 | 1.51 | 6.21 |
Total Current Liabilities & Provisions | 308.83 | 329.67 | 776.32 | 364.65 | 322.89 | 337.89 | 320.99 | 308.61 | 253.45 | 334.12 |
Net Current Assets | 135.99 | 219.23 | 169.24 | 146.32 | 360.38 | 170 | 237.33 | 224.56 | 292.41 | 186.62 |
Deferred Tax Assets | 76.72 | 79.89 | 127.44 | 120.28 | 135.63 | 167.22 | 219.22 | 246.7 | 84.03 | 89.11 |
Deferred Tax Liability | 99.27 | 100.26 | 103.69 | 120.13 | 133.68 | 147.43 | 208.82 | 228.29 | 84.53 | 89.59 |
Net Deferred Tax | -22.55 | -20.37 | 23.75 | 0.15 | 1.95 | 19.79 | 10.4 | 18.41 | -0.5 | -0.48 |
Other Assets | 72.08 | 66.5 | 145.16 | 23.23 | 18.11 | 14.45 | 33.4 | 198.41 | 67.78 | 94.77 |
Total Assets | 909.3 | 921.13 | 982.55 | 812.89 | 1,067.41 | 1,037.64 | 1,277.31 | 1,480.44 | 1,600.46 | 1,595.87 |
Contingent Liabilities | 369.39 | 655.75 | 368.17 | 406.99 | 366.93 | 404.06 | 378.64 | 364.27 | 353.54 | 353.5 |
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | Mar 2015 | |
SOURCES OF FUNDS : | ||||||||||
Share Capital | 12.12 | 11.11 | 6.13 | 6.13 | 6.13 | 6.13 | 15.59 | 6.13 | 22.43 | 22.43 |
Reserves Total | 301.36 | 297.87 | 387.32 | 480.39 | 832.82 | 402.71 | 372.33 | 440.06 | 517.6 | 517.28 |
Equity Share Warrants | 0 | 0 | 0 | 0 | 32 | 0 | 0 | 0 | 0 | 0 |
Equity Application Money | 21.65 | 21.65 | 21.65 | 21.65 | 21.79 | 9.64 | 9.64 | 9.64 | 0 | 0 |
Total Shareholders Funds | 335.13 | 330.63 | 415.1 | 508.17 | 892.74 | 418.48 | 397.56 | 455.83 | 540.03 | 539.71 |
Secured Loans | 0 | 0.24 | 0.29 | 5.05 | 12.44 | 604.57 | 906.96 | 959.87 | 962.38 | 955.95 |
Unsecured Loans | 118.87 | 97.23 | 83.87 | 60.03 | 54.8 | 84.11 | 53.27 | 62.65 | 56.71 | 58.81 |
Total Debt | 118.87 | 97.47 | 84.16 | 65.08 | 67.24 | 688.68 | 960.23 | 1,022.52 | 1,019.09 | 1,014.76 |
Other Liabilities | 25.85 | 20.21 | 15.88 | 20.52 | 17.97 | 14.17 | 29.42 | 21.97 | 14.52 | 12.38 |
Total Liabilities | 479.85 | 448.31 | 515.14 | 593.77 | 977.95 | 1,121.33 | 1,387.21 | 1,500.32 | 1,573.64 | 1,566.85 |
APPLICATION OF FUNDS : | ||||||||||
Gross Block | 900.61 | 908.57 | 907.86 | 893.02 | 905.42 | 813.95 | 1,542.55 | 1,536.97 | 1,518.16 | 1,532.12 |
Less : Accumulated Depreciation | 477.58 | 473.21 | 453.83 | 428.77 | 406.14 | 317.52 | 651.62 | 594.95 | 530.58 | 472.44 |
Net Block | 423.03 | 435.36 | 454.03 | 464.25 | 499.28 | 496.43 | 890.93 | 942.02 | 987.58 | 1,059.68 |
Capital Work in Progress | 96.54 | 27.85 | 0.88 | 12.97 | 3.74 | 3.1 | 37.16 | 27.68 | 19.01 | 16.98 |
Investments | 0.27 | 0.27 | 0.27 | 0.27 | 2.55 | 2.54 | 344.88 | 344.88 | 394.66 | 394.66 |
Inventories | 107.93 | 116.1 | 129.25 | 87.04 | 99.23 | 42.51 | 149.1 | 140.6 | 136.57 | 140.9 |
Sundry Debtors | 11.08 | 12.27 | 23.32 | 35.29 | 17.69 | 25.2 | 142.27 | 175.8 | 142.21 | 100.43 |
Cash and Bank Balance | 29.44 | 43.25 | 42.69 | 88.96 | 60.61 | 7.85 | 11.79 | 7.21 | 9.32 | 42.37 |
Loans and Advances | 34.76 | 27.52 | 53.57 | 81.26 | 436.8 | 840.55 | 50.5 | 80.08 | 53.01 | 31.47 |
Total Current Assets | 183.2 | 199.14 | 248.82 | 292.55 | 614.32 | 916.1 | 353.65 | 403.7 | 341.11 | 315.17 |
Current Liabilities | 219.02 | 222.06 | 217.84 | 192.08 | 157.44 | 311.05 | 279.5 | 279.99 | 232.42 | 307.23 |
Provisions | 29.97 | 28.74 | 28.86 | 4.44 | 3.1 | 9.66 | 6.79 | 1.45 | 1.37 | 5.15 |
Total Current Liabilities & Provisions | 248.98 | 250.79 | 246.7 | 196.52 | 160.54 | 320.72 | 286.29 | 281.45 | 233.79 | 312.38 |
Net Current Assets | -65.78 | -51.66 | 2.12 | 96.03 | 453.77 | 595.39 | 67.36 | 122.25 | 107.32 | 2.79 |
Deferred Tax Assets | 46.02 | 46.02 | 72.09 | 0 | 135.13 | 166.64 | 203.13 | 234.63 | 84.03 | 89.11 |
Deferred Tax Liability | 70.82 | 70.82 | 72.09 | 0 | 133.68 | 147.43 | 181.14 | 202.76 | 84.03 | 89.11 |
Net Deferred Tax | -24.8 | -24.8 | 0 | 0 | 1.45 | 19.21 | 21.99 | 31.87 | 0 | 0 |
Other Assets | 50.6 | 61.3 | 57.83 | 20.25 | 17.16 | 4.65 | 24.89 | 31.61 | 65.07 | 92.74 |
Total Assets | 479.86 | 448.31 | 515.13 | 593.77 | 977.95 | 1,121.33 | 1,387.21 | 1,500.31 | 1,573.64 | 1,566.85 |
Contingent Liabilities | 369.39 | 655.75 | 368.17 | 406.99 | 366.93 | 404.06 | 378.64 | 364.27 | 353.54 | 353.5 |
Cash Flow (Figures in Rs. Crores)
Net Profit before Tax and Extr... | 1.48 |
Depreciation | 36.71 |
Interest (Net) | -4.79 |
Dividend Received | 0.01 |
P/L on Sales of Assets | 4.56 |
P/L on Sales of Invest | -3.37 |
Prov. and W/O (Net) | -5.96 |
P/L in Forex | 0.13 |
Total Adjustments (PBT and Ext... | -8.76 |
Operating Profit before Workin... | -7.28 |
Trade and 0ther Receivables | 2.96 |
Inventories | 24.16 |
Loans and Advances | -27.96 |
Total Adjustments (OP before W... | 9.69 |
Cash Generated from/(used in) ... | 2.41 |
Direct Taxes Paid | -2.51 |
Total Adjustments(Cash Generat... | -2.51 |
Cash Flow before Extraordinary... | -0.1 |
Net Cash from Operating Activi... | -0.1 |
Purchased of Fixed Assets | -77.72 |
Sale of Fixed Assets | 6.68 |
Purchase of Investments | -301.66 |
Sale of Investments | 278.09 |
Interest Received | 8.37 |
Inter Corporate Deposits | 142.05 |
Net Cash used in Investing Act... | 10.23 |
Of the Long Tem Borrowings | -0.24 |
Interest Paid | -2.57 |
Net Cash used in Financing Act... | -2.81 |
Net Profit before Tax and Extr... | 4.21 |
Depreciation | 21.09 |
Interest (Net) | -1.44 |
Dividend Received | 0.01 |
P/L on Sales of Assets | 0.45 |
Prov. and W/O (Net) | 10.08 |
P/L in Forex | 0.79 |
Total Adjustments (PBT and Ext... | 30.95 |
Operating Profit before Workin... | 35.16 |
Trade and 0ther Receivables | 1.28 |
Inventories | 8.17 |
Loans and Advances | -7.95 |
Total Adjustments (OP before W... | 4 |
Cash Generated from/(used in) ... | 39.15 |
Direct Taxes Paid | -1.88 |
Total Adjustments(Cash Generat... | -1.88 |
Cash Flow before Extraordinary... | 37.27 |
Net Cash from Operating Activi... | 37.27 |
Purchased of Fixed Assets | -75.03 |
Sale of Fixed Assets | 6.64 |
Interest Received | 3.72 |
Net Cash used in Investing Act... | -51.01 |
Proceed from 0ther Long Term B... | 215.34 |
Of the Long Tem Borrowings | -193.93 |
Interest Paid | -8.59 |
Net Cash used in Financing Act... | 12.82 |
Company Details
Registered Office |
|
Address | Ambala-Chandigarh Highway, |
City | Lalru |
State | Punjab |
Pin Code | 140501 |
Tel. No. | 91-1762-505900 |
Fax. No. | |
corporate@panaceabiotec.com; investorgrievances@pa | |
Internet | http://www.panaceabiotec.com |
Registrars |
|
Address | Ambala-Chandigarh Highway |
City | Lalru |
State | Punjab |
Pin Code | 140501 |
Tel. No. | 91-1762-505900 |
Fax. No. | |
corporate@panaceabiotec.com; investorgrievances@pa | |
Internet | http://www.panaceabiotec.com |
Management |
|
Name | Designation |
Rajesh Jain | Chairman & Managing Director |
Sandeep Jain | Joint Managing Director |
R L Narasimhan | Non-Exec. & Independent Dir. |
N N Khamitkar | Non-Exec. & Independent Dir. |
K M Lal | Non-Exec. & Independent Dir. |
Vinod Goel | Group CFO & Company Secretary |
Manjula Upadhyay | Non-Exec. & Independent Dir. |
Mukul Gupta | Non-Exec. & Independent Dir. |
Ankesh Jain | Whole-time Director |
BHUPINDER SINGH | Non-Exec. & Independent Dir. |
Narotam Kumar Juneja | Non Executive Director |
Rajesh Jain | Additional Director |